NASDAQ
Elite Pharmaceuticals, Inc. (ELTP) has a free cash flow growth of -209.67% as of Friday, May 29, 2026. This represents a 263.18% decrease compared to its 12-month average of 128.49%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.